Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation

PHASE2CompletedINTERVENTIONAL

Enrollment

273

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Irritable Bowel SyndromeConstipation

Interventions

DRUG

YKP10811 5mg

DRUG

YKP10811 20mg

DRUG

YKP10811 placebo

Trial Locations (1)

Gang Nam Severance Hospital, Gang Nam Gu

All Listed Sponsors

lead

SK Chemicals Co., Ltd.

INDUSTRY

NCT02082457 - Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation | Biotech Hunter | Biotech Hunter